Literature DB >> 31162702

The impact of demographic factors on newborn TSH levels and congenital hypothyroidism screening.

Natasha L Heather1,2, José G B Derraik2,3,4, Dianne Webster1, Paul L Hofman2,5.   

Abstract

CONTEXT: Optimal newborn screening thyroid-stimulating hormone (TSH) cut-offs are contentious. Analysis of demographic factors that impact screen TSH levels may help explain international variance and provide guidance to screening programmes.
OBJECTIVE: To determine the influence of demographic factors on newborn screening TSH levels and screening performance parameters. DESIGN AND
SETTING: National, retrospective population study using blood spot TSH cards from the New Zealand newborn screening programme in 2010-2015. PATIENTS: 325 685 blood spot cards. MAIN OUTCOME MEASURES: Likelihood of exceeding specific TSH thresholds (TSH ≥5, ≥10 and ≥15 mIU/L) and group-specific screening performance parameters.
RESULTS: The likelihood of high TSH levels differed between ethnic groups. Pacific Island infants were more than twice as likely to have high-normal TSH levels (≥5 and ≥10 mIU/L) and nearly twice as likely to have a positive screen (≥15 mIU/L) as New Zealand Europeans. Māori or Chinese ethnicity, male sex, younger gestational age and greater socio-economic deprivation scores were also associated with high-normal TSH levels. At a TSH threshold ≥15 mIU/L, screening sensitivity was lowest (88.89% vs 95.83% overall) and PPV greatest (88.89% vs 62.84%) amongst Asian infants. Early samples were more than three times as likely to reach the screen-positive threshold and more likely to yield a false-positive result (PPV 20.00% vs 68.87%, P = 0.004).
CONCLUSIONS: Newborn TSH levels are impacted by a number of demographic variables, particularly ethnicity and age at sample collection. Screening performance may be improved through the use of targeted thresholds.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  congenital hypothyroidism; demographic factors; ethnicity; newborn screening; thyroid-stimulating hormone (TSH)

Year:  2019        PMID: 31162702     DOI: 10.1111/cen.14044

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

Review 1.  It All Depends What You Count-The Importance of Definitions in Evaluation of CF Screening Performance.

Authors:  Natasha Heather; Dianne Webster
Journal:  Int J Neonatal Screen       Date:  2020-06-10

2.  Validity of Six Month L-Thyroxine Dose for Differentiation of Transient or Permanent Congenital Hypothyroidism

Authors:  Muhammet Asena; Meliha Demiral; Edip Unal; Murat Öcal; Hüseyin Demirbilek; Mehmet Nuri Özbek
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.